Rocket Pharmaceuticals Warrant
RCKTW
10 hedge funds and large institutions have $538K invested in Rocket Pharmaceuticals Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
1.19% less ownership
Funds ownership: 3.54% → 2.35% (-1.2%)
29% less funds holding
Funds holding: 14 → 10 (-4)
40% less capital invested
Capital invested by funds: $904K → $538K (-$366K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$3.7K |
| 2 |
Walleye Trading
New York
|
+$2.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$51.2K |
| 2 |
FBCM
Fort Baker Capital Management
Larkspur,
California
|
-$23.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.37K |
| 4 |
Walleye Capital
New York
|
-$2.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$283 |
RCKTW Hedge Fund Activity: Q4 2024 in Review
10 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q4 2024, worth a combined $538K — down 40% from $904K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of RCKTW and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was LMR Partners, opening a new position worth an estimated $3.7K. The largest seller was Altium Capital Management, exiting entirely with an estimated $51.2K sold.
- 10 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q4 2024, down from 14 in Q3 2024.
- Funds reported $538K of Rocket Pharmaceuticals Warrant stock for Q4 2024, down 40% quarter-over-quarter.
- 1 fund opened new Rocket Pharmaceuticals Warrant positions in Q4 2024 and 5 closed out, a net change of -4 holders.
- The largest Rocket Pharmaceuticals Warrant buyer in Q4 2024 was LMR Partners, an estimated $3.7K added.
- The largest Rocket Pharmaceuticals Warrant seller in Q4 2024 was Altium Capital Management, an estimated $51.2K sold.
Based on aggregated 13F filings for Q4 2024.